Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
PIK3CD expression
i
Other names:
PIK3CD, Phosphatidylinositol-4 5-Bisphosphate 3-Kinase Catalytic Subunit Delta, Phosphatidylinositol 4 5-Bisphosphate 3-Kinase Catalytic Subunit Delta Isoform, PtdIns-3-Kinase Subunit P110-Delta, Phosphoinositide-3-Kinase C, PI3Kdelta, Phosphatidylinositol-4 5-Bisphosphate 3-Kinase Catalytic Subunit Delta Short Variant 8/20, Phosphatidylinositol-4 5-Bisphosphate 3-Kinase Catalytic Subunit Delta Short Variant 20, Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Delta Short Variant
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
5293
Related biomarkers:
Expression
Mutation
‹
PIK3CD mutation (1)
PIK3CD mutation (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
PIK3CD expression
Mantle Cell Lymphoma
PIK3CD expression
Mantle Cell Lymphoma
NBL-001
Sensitive: D – Preclinical
NBL-001
Sensitive
:
D
NBL-001
Sensitive: D – Preclinical
NBL-001
Sensitive
:
D
PIK3CD expression
Squamous Cell Carcinoma of Head and Neck
PIK3CD expression
Squamous Cell Carcinoma of Head and Neck
duvelisib
Sensitive: D – Preclinical
duvelisib
Sensitive
:
D
duvelisib
Sensitive: D – Preclinical
duvelisib
Sensitive
:
D
PIK3CD expression
Melanoma
PIK3CD expression
Melanoma
duvelisib
Sensitive: D – Preclinical
duvelisib
Sensitive
:
D
duvelisib
Sensitive: D – Preclinical
duvelisib
Sensitive
:
D
PIK3CD expression
Mantle Cell Lymphoma
PIK3CD expression
Mantle Cell Lymphoma
copanlisib
Sensitive: D – Preclinical
copanlisib
Sensitive
:
D
copanlisib
Sensitive: D – Preclinical
copanlisib
Sensitive
:
D
PIK3CD expression
Mantle Cell Lymphoma
PIK3CD expression
Mantle Cell Lymphoma
copanlisib + NBL-001
Sensitive: D – Preclinical
copanlisib + NBL-001
Sensitive
:
D
copanlisib + NBL-001
Sensitive: D – Preclinical
copanlisib + NBL-001
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.